Clinical Trial Monitoring

Clinical Monitoring Services

SanaClis provides these clinical monitoring services for phases I-IV:

  • Feasibility process & Site selection
  • Analysis of competitive studies and site workload
  • Pre-study site evaluation visits
  • Set up of investigational sites
  • Investigator meeting (preparation, travel arrangements, conduct)
  • Study initiation
  • Site monitoring
  • Site management between the visits
  • Close-out visits and archiving

Phase I can be done for example in Czech Republic, Romania, Georgia, Ukraine and Russia. Phases II- IV can be done in the following countries in Central & Eastern Europe (both EU and non-EU countries). For further informations see LOCATIONS.

Therapeutic Expertise

SanaClis can perform clinical monitoring in any therapeutic area, including rare indications. We actively use country databases of sites participating in clinical trials. In 94% of our studies planned recruitment tagrets were exceeded or reached earlier. We have experience and pools of reliable investigators in the various therapeutic areas.

We carefully pick our CRAs with focus on following criteria:

  • University education
  • Good command of English
  • Monitorig experience - most of CRAs have more than 2 years of clinical monitoring experience
  • Availability & flexibility

We keep our CRAs highly motivated with strong social benefits, therefore the turnover is close to zero. They are also provided with:

  • All necessary trainings according to SanaClis SOPs and individual training plans
  • Therapeutic area training
  • Supervised monitoring experience of at least 6 months before starting solo
  • Bonuses related to site quality and achievement of recruitment targets
  • SanaClis quality and safety net

Our CRAs are experienced in active assistance with technical difficulties occuring at the site. They can also provide the site with any support, both proactive and on demand. As a result, SanaClis CRAs have mutually respectful and long-lasting working relationships with the investigators.